Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Webinars and Reports

Roche Diagnostics Middle East Webinar – Management of cardiovascular risks of COVID-19 patients

Webinar-Roche Diagnostics Middle East Webinar – Management of cardiovascular risks of COVID-19 patients

This webinar from Roche Diagnostics Middle East FZCO will shed light on how cardiac involvement due to acute myocarditis may occur in patients with COVID-19 without respiratory tract signs and symptoms of infection.

By viewing this on-demand webinar you will come away with a greater understanding of: 

  • The potential mechanisms underlying cardiac biomarkers elevation with COVID-19 infections
  • What biomarkers should be tested and when for the diagnosis of cardiovascular conditions in COVID-19 patients 
  • Value of cardiac biomarkers in COVID-19 patient management



januuzzi_90x90.jpgProfessor James L. Januzzi Jr, MD, FACC, FESC

Hutter Family Professor of Medicine, Harvard Medical School;
Physician, Cardiology Division, Massachusetts General Hospital;
Cardiometabolic Faculty, Baim Institute for Clinical Research;
Trustee, American College of Cardiology;
Boston, US


tijana_90x90.jpgTijana Krnjeta Janicijevic, PharmD PhD

Tijana Krnjeta Janicijevic is a Senior International Medical Affairs Manager in Roche Diagnostics International.

Tijana holds PhD in pharmacy from Faculty of Pharmacy, University of Belgrade.

She has been working for Roche Diagnostics since 2009, and went through various roles with increasing responsibilities and expertise’s. Currently Tijana is responsible for global medical strategy for biomarkers in heart failure management, leading global medical education activities as well as further clinical evidence generation.

TAGS: Cardiology